These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3381756)

  • 1. Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias.
    Kelly PA; Cannom DS; Garan H; Finkelstein D; McComb JM; Mirabal GS; Ilvento JP; Ruskin JN
    Am J Cardiol; 1988 Jul; 62(1):83-7. PubMed ID: 3381756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.
    Kay GN; Plumb VJ; Dailey SM; Epstein AE
    Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined automatic implantable cardioverter-defibrillator and pacemaker systems: implantation techniques and follow-up.
    Epstein AE; Kay GN; Plumb VJ; Shepard RB; Kirklin JK
    J Am Coll Cardiol; 1989 Jan; 13(1):121-31. PubMed ID: 2909559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with the use of an implantable automatic cardioverter defibrillator].
    Dórticos F; Zayas R; Dorantes M; Tain J; Bueno J; Carballido J; Sainz H
    Arch Inst Cardiol Mex; 1990; 60(5):499-502. PubMed ID: 2091555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of automatic cardioverter-defibrillators via median sternotomy.
    Brodman R; Fisher JD; Furman S; Johnston DR; Kim SG; Matos JA; Waspe LE
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 2):1363-9. PubMed ID: 6209684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant ventricular arrhythmias with the automatic implantable cardioverter defibrillator.
    Slater AD; Singer I; Stavens CS; Zee-Cheng C; Ganzel BL; Kupersmith J; Mavroudis C; Gray LA
    Ann Surg; 1989 May; 209(5):635-41; discussion 641. PubMed ID: 2705827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks.
    Kou WH; Calkins H; Lewis RR; Bolling SF; Kirsch MM; Langberg JJ; de Buitleir M; Sousa J; el-Atassi R; Morady F
    Ann Intern Med; 1991 Dec; 115(12):942-5. PubMed ID: 1952491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival.
    Kelly P; Ruskin JN; Vlahakes GJ; Buckley MJ; Freeman CS; Garan H
    J Am Coll Cardiol; 1990 Feb; 15(2):267-73. PubMed ID: 2299065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and depression in patients with life-threatening ventricular arrhythmias: impact of the implantable cardioverter-defibrillator.
    Keren R; Aarons D; Veltri EP
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 1):181-7. PubMed ID: 1706503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with the automatic implantable cardioverter defibrillator in sudden death survivors.
    Paull DL; Fellows CL; Guyton SW; Anderson RP
    Am J Surg; 1989 May; 157(5):516-8. PubMed ID: 2712211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators.
    Levine JH; Mellits ED; Baumgardner RA; Veltri EP; Mower M; Grunwald L; Guarnieri T; Aarons D; Griffith LS
    Circulation; 1991 Aug; 84(2):558-66. PubMed ID: 1860200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease.
    de Marchena E; Chakko S; Fernandez P; Villa A; Cooper D; Wozniak P; Cruz J; Thurer RJ; Kessler KM; Myerburg RJ
    Am J Cardiol; 1991 Apr; 67(9):812-6. PubMed ID: 2011982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the prolonged QT syndrome and recurrent ventricular fibrillation with an implantable automatic cardioverter-defibrillator.
    Platia EV; Griffith LS; Watkins L; Mirowski M; Mower MM; Reid PR
    Clin Cardiol; 1985 Sep; 8(9):490-3. PubMed ID: 4042451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias.
    Kelly PA; Cannom DS; Garan H; Mirabal GS; Harthorne JW; Hurvitz RJ; Vlahakes GJ; Jacobs ML; Ilvento JP; Buckley MJ
    J Am Coll Cardiol; 1988 Jun; 11(6):1278-86. PubMed ID: 3367002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic implantable cardioverter defibrillator/permanent pacemaker interaction: loss of pacemaker capture following AICD discharge.
    Slepian M; Levine JH; Watkins L; Brinker J; Guarnieri T
    Pacing Clin Electrophysiol; 1987 Sep; 10(5):1194-7. PubMed ID: 2444945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.